Found: 14
Select item for more details and to access through your institution.
Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
- Published in:
- Liver International, 2009, v. 29, n. 9, p. 1403, doi. 10.1111/j.1478-3231.2009.02060.x
- By:
- Publication type:
- Article
Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 6, p. 709, doi. 10.1111/apt.17308
- By:
- Publication type:
- Article
Editorial: let's get physical—long‐term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Hypothetical treatment of patients with non‐alcoholic steatohepatitis: Potential impact on important clinical outcomes.
- Published in:
- Liver International, 2020, v. 40, n. 2, p. 308, doi. 10.1111/liv.14292
- By:
- Publication type:
- Article
Patient‐reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication.
- Published in:
- Liver International, 2019, v. 39, n. 10, p. 1837, doi. 10.1111/liv.14171
- By:
- Publication type:
- Article
Viral eradication is required for sustained improvement of patient‐reported outcomes in patients with hepatitis C.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 54, doi. 10.1111/liv.13900
- By:
- Publication type:
- Article
The impact of hepatocellular carcinoma diagnosis on patients' health‐related quality of life.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6273, doi. 10.1002/cam4.4166
- By:
- Publication type:
- Article
Outcomes of Liver Transplantation by Insurance Type in the United States.
- Published in:
- American Journal of Managed Care, 2020, v. 26, n. 4, p. e121, doi. 10.37765/ajmc.2020.42839
- By:
- Publication type:
- Article
Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 4, p. 628, doi. 10.1093/cid/ciz243
- By:
- Publication type:
- Article
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 11, p. 1015, doi. 10.1111/jvh.13741
- By:
- Publication type:
- Article
Development and validation of a hepatitis B‐specific health‐related quality‐of‐life instrument: CLDQ‐HBV.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 3, p. 484, doi. 10.1111/jvh.13451
- By:
- Publication type:
- Article
The impact of modifiable risk factors on the long‐term outcomes of non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 2, p. 291, doi. 10.1111/apt.15580
- By:
- Publication type:
- Article
Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.
- Published in:
- 2020
- By:
- Publication type:
- journal article